Overview
Lobbying Costs
10,000€ - 24,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Dompé farmaceutici spa
EU Transparency Register
558526138218-10 First registered on 19 May 2020
Goals / Remit
L’attività di Dompé è finalizzata alla ricerca e allo sviluppo di soluzioni terapeutiche biofarmaceutiche, attraverso la gestione diretta dell’intera filiera, dalla fase iniziale di ricerca di base e preclinica, fino alla produzione e commercializzazione finale. Le attività di ricerca si sviluppano sia nell’ambito della Primary Care sia in quello Biotech. La Primary Care comprende un ampio spettro di soluzioni terapeutiche OTC, farmaci etici, integratori e dispositivi medici disponibili in farmacia. Il Biotech è concentrato sullo sviluppo di terapie per il trattamento di malattie rare a elevato impatto sociale. I principali ambiti terapeutici riguardano il dolore, l’infiammazione, l’oftalmologia, la diabetologia, l’alimentazione e l’oncologia.L’impegno di Dompé nel progresso della conoscenza scientifica si concretizza in pubblicazioni scientifiche di rilievo e nello sviluppo di collaborazioni con specifici centri di ricerca e università.
Main EU files targeted
Dompé farmaceutici è capofila del progetto Exscalate4Cov supported by the European Commission: https://ec.europa.eu/info/research-and-innovation/research-area/health-research-and-innovation/coronavirus-research-and-innovation/infrastructures-and-resources_en#exscalate
Address
Head Office
Via San Martino 12
Milano
ITALYEU Office
Via San Martino 12
Milano
ITALYWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Farmindustria - https://www.farmindustria.it/
Assolombarda - https://www.assolombarda.it/Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
10,000€ - 24,999€
Major contributions in closed year
None declared
Intermediaries for closed year
None declaredIntermediaries for current year
None declaredClosed year Costs
10,000€ - 24,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
Progetto Exscalate4Cov nell'ambito dell'urgent computing per combattere la pandemia del Covid-19 - parte di H2020
Progetto Remed4All per il repurposing di farmaci contro Covid e tumori al fegato.Other activities
Dompé farmaceutici è capofila del progetto Exscalate4Cov supported by the European Commission: https://ec.europa.eu/info/research-and-innovation/research-area/health-research-and-innovation/coronavirus-research-and-innovation/infrastructures-and-resources_en#exscalate
Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 30 Oct 2020 Location Brussels Subject Covid-19 - videomeeting DG Communications Networks, Content and Technology Attending - Roberto Viola (Director-General)
-
Date 30 Oct 2020 Location Brussels Subject Covid-19 - videomeeting DG Communications Networks, Content and Technology Attending - Roberto Viola (Director-General)
-
Date 18 May 2020 Location videoconference Subject Exscalate4COV Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
- Fabrice Comptour (Cabinet member)